News | November 07, 2024
Mitsui Chemicals invests in clinical kidney disease drug developer Rege Nephro
The company uses iPS cells to develop treatments for diseases relating to the kidney
The company uses iPS cells to develop treatments for diseases relating to the kidney
The company can now expand its business horizon into the area of pharmaceutical applications in the USA
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
H.coagulans is, unlike other general lactobacillus, characterized by spore formation, giving it resistance to acid and heat
The company reported total income at Rs. 509.8 crore in Q1 FY25 as compared to Rs. 570.3 crore in Q1 FY24
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
EDQM has also issued a Certificate of Suitability for Allopurino
The award recognizes powerful science–industry collaborations for social good
Subscribe To Our Newsletter & Stay Updated
